

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 7.64991833 |
| 2 | myelination (GO:0042552) | 6.45232788 |
| 3 | ensheathment of neurons (GO:0007272) | 6.44303404 |
| 4 | axon ensheathment (GO:0008366) | 6.44303404 |
| 5 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 6.39315822 |
| 6 | glutamate secretion (GO:0014047) | 5.96527469 |
| 7 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.96419281 |
| 8 | cellular potassium ion homeostasis (GO:0030007) | 5.91628630 |
| 9 | sodium ion export (GO:0071436) | 5.63514147 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 5.58413266 |
| 11 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.48962249 |
| 12 | myelin maintenance (GO:0043217) | 5.37581303 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.96263315 |
| 14 | negative regulation of neurotransmitter transport (GO:0051589) | 4.86706387 |
| 15 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.82187416 |
| 16 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.81126508 |
| 17 | response to methylmercury (GO:0051597) | 4.67527526 |
| 18 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.65782690 |
| 19 | establishment of mitochondrion localization (GO:0051654) | 4.59623107 |
| 20 | negative regulation of protein localization to cell surface (GO:2000009) | 4.57197462 |
| 21 | cholesterol biosynthetic process (GO:0006695) | 4.52762045 |
| 22 | potassium ion homeostasis (GO:0055075) | 4.49250121 |
| 23 | potassium ion import (GO:0010107) | 4.42692100 |
| 24 | L-amino acid import (GO:0043092) | 4.33472315 |
| 25 | regulation of collateral sprouting (GO:0048670) | 4.30509323 |
| 26 | regulation of synaptic vesicle transport (GO:1902803) | 4.29355197 |
| 27 | neurotransmitter secretion (GO:0007269) | 4.23789122 |
| 28 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.19593838 |
| 29 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.18758217 |
| 30 | creatine metabolic process (GO:0006600) | 4.15747712 |
| 31 | amyloid precursor protein metabolic process (GO:0042982) | 4.12956951 |
| 32 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.11578019 |
| 33 | oligodendrocyte differentiation (GO:0048709) | 4.08601740 |
| 34 | cell communication by electrical coupling (GO:0010644) | 4.04499366 |
| 35 | sterol biosynthetic process (GO:0016126) | 4.03505183 |
| 36 | regulation of cell communication by electrical coupling (GO:0010649) | 3.95521108 |
| 37 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.93665738 |
| 38 | positive regulation of synapse maturation (GO:0090129) | 3.90671909 |
| 39 | glycerophospholipid catabolic process (GO:0046475) | 3.89913261 |
| 40 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.83149962 |
| 41 | eye photoreceptor cell differentiation (GO:0001754) | 3.81633577 |
| 42 | photoreceptor cell differentiation (GO:0046530) | 3.81633577 |
| 43 | locomotory exploration behavior (GO:0035641) | 3.81321779 |
| 44 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.78667068 |
| 45 | presynaptic membrane organization (GO:0097090) | 3.77179022 |
| 46 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.76465060 |
| 47 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.76381143 |
| 48 | apical protein localization (GO:0045176) | 3.73039666 |
| 49 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.69933287 |
| 50 | substantia nigra development (GO:0021762) | 3.68781080 |
| 51 | cellular sodium ion homeostasis (GO:0006883) | 3.66795805 |
| 52 | astrocyte development (GO:0014002) | 3.62291050 |
| 53 | regulation of lipoprotein metabolic process (GO:0050746) | 3.61160458 |
| 54 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.58962555 |
| 55 | asymmetric protein localization (GO:0008105) | 3.58717064 |
| 56 | import into cell (GO:0098657) | 3.56886329 |
| 57 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.54400340 |
| 58 | detection of calcium ion (GO:0005513) | 3.53592635 |
| 59 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.52438853 |
| 60 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.50952461 |
| 61 | isoprenoid biosynthetic process (GO:0008299) | 3.49991870 |
| 62 | response to redox state (GO:0051775) | 3.49385351 |
| 63 | vocalization behavior (GO:0071625) | 3.49323126 |
| 64 | neurotransmitter transport (GO:0006836) | 3.49072154 |
| 65 | cell communication involved in cardiac conduction (GO:0086065) | 3.45197262 |
| 66 | neuromuscular process controlling balance (GO:0050885) | 3.43260978 |
| 67 | acidic amino acid transport (GO:0015800) | 3.42740441 |
| 68 | regulation of synaptic plasticity (GO:0048167) | 3.42389592 |
| 69 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.39253949 |
| 70 | postsynaptic membrane organization (GO:0001941) | 3.39031181 |
| 71 | membrane tubulation (GO:0097320) | 3.38309200 |
| 72 | adult walking behavior (GO:0007628) | 3.35610029 |
| 73 | positive regulation of dendritic spine development (GO:0060999) | 3.33532167 |
| 74 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.30286845 |
| 75 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.28919780 |
| 76 | presynaptic membrane assembly (GO:0097105) | 3.28571499 |
| 77 | response to lipoprotein particle (GO:0055094) | 3.27723965 |
| 78 | regulation of neurotransmitter levels (GO:0001505) | 3.26425968 |
| 79 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.26022340 |
| 80 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.25953569 |
| 81 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.23963021 |
| 82 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.23462936 |
| 83 | neurotransmitter uptake (GO:0001504) | 3.22484761 |
| 84 | exploration behavior (GO:0035640) | 3.21847133 |
| 85 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.21670577 |
| 86 | amino acid import (GO:0043090) | 3.20434637 |
| 87 | protein palmitoylation (GO:0018345) | 3.18925216 |
| 88 | regulation of synapse structural plasticity (GO:0051823) | 3.18801903 |
| 89 | negative regulation of inclusion body assembly (GO:0090084) | 3.16949658 |
| 90 | peripheral nervous system axon ensheathment (GO:0032292) | 3.15196158 |
| 91 | myelination in peripheral nervous system (GO:0022011) | 3.15196158 |
| 92 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.15126782 |
| 93 | synaptic transmission, glutamatergic (GO:0035249) | 3.14651931 |
| 94 | neuronal action potential propagation (GO:0019227) | 3.13215191 |
| 95 | very long-chain fatty acid metabolic process (GO:0000038) | 3.13172439 |
| 96 | regulation of neurotransmitter secretion (GO:0046928) | 3.12671429 |
| 97 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.11900569 |
| 98 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.09555037 |
| 99 | L-glutamate transport (GO:0015813) | 3.05363370 |
| 100 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.04212851 |
| 101 | positive regulation of membrane potential (GO:0045838) | 3.02427071 |
| 102 | regulation of synapse maturation (GO:0090128) | 3.01813967 |
| 103 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.00766531 |
| 104 | axon development (GO:0061564) | 2.99358841 |
| 105 | long-term synaptic potentiation (GO:0060291) | 2.99314919 |
| 106 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.98384354 |
| 107 | cerebellar Purkinje cell layer development (GO:0021680) | 2.98378962 |
| 108 | neuron cell-cell adhesion (GO:0007158) | 2.97829596 |
| 109 | negative regulation of axonogenesis (GO:0050771) | 2.96451073 |
| 110 | protein neddylation (GO:0045116) | 2.95892275 |
| 111 | magnesium ion transport (GO:0015693) | 2.95376353 |
| 112 | regulation of dendritic spine development (GO:0060998) | 2.95257073 |
| 113 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.94175636 |
| 114 | regulation of neurotransmitter transport (GO:0051588) | 2.91826173 |
| 115 | regulation of ARF protein signal transduction (GO:0032012) | 2.90548442 |
| 116 | transmission of nerve impulse (GO:0019226) | 2.89911067 |
| 117 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.89573555 |
| 118 | neuron-neuron synaptic transmission (GO:0007270) | 2.89105971 |
| 119 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.88853425 |
| 120 | neuron remodeling (GO:0016322) | 2.87105743 |
| 121 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.86584632 |
| 122 | cardiac muscle contraction (GO:0060048) | 2.85707919 |
| 123 | glutamate receptor signaling pathway (GO:0007215) | 2.85263221 |
| 124 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.84365301 |
| 125 | regulation of actin filament-based movement (GO:1903115) | 2.84148150 |
| 126 | glycosylceramide metabolic process (GO:0006677) | 2.83901779 |
| 127 | GPI anchor biosynthetic process (GO:0006506) | 2.83403433 |
| 128 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.81666479 |
| 129 | long-term memory (GO:0007616) | 2.80817618 |
| 130 | membrane depolarization during action potential (GO:0086010) | 2.78671156 |
| 131 | nerve growth factor signaling pathway (GO:0038180) | 2.78419034 |
| 132 | glycine transport (GO:0015816) | 2.77128879 |
| 133 | synaptic vesicle endocytosis (GO:0048488) | 2.75991351 |
| 134 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.74414099 |
| 135 | limb bud formation (GO:0060174) | 2.74211979 |
| 136 | regulation of synaptic transmission (GO:0050804) | 2.74164492 |
| 137 | amyloid precursor protein catabolic process (GO:0042987) | 2.73573166 |
| 138 | regulation of postsynaptic membrane potential (GO:0060078) | 2.72657270 |
| 139 | relaxation of smooth muscle (GO:0044557) | 2.72613533 |
| 140 | GPI anchor metabolic process (GO:0006505) | 2.72251948 |
| 141 | positive regulation of potassium ion transport (GO:0043268) | 2.72207364 |
| 142 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.71885457 |
| 143 | thioester biosynthetic process (GO:0035384) | 2.70249006 |
| 144 | acyl-CoA biosynthetic process (GO:0071616) | 2.70249006 |
| 145 | astrocyte differentiation (GO:0048708) | 2.69753104 |
| 146 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.69675110 |
| 147 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.67672902 |
| 148 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.67672902 |
| 149 | adhesion of symbiont to host cell (GO:0044650) | 2.61817990 |
| 150 | virion attachment to host cell (GO:0019062) | 2.61817990 |
| 151 | iron coordination entity transport (GO:1901678) | 2.60664334 |
| 152 | peptidyl-cysteine modification (GO:0018198) | 2.60592622 |
| 153 | peripheral nervous system development (GO:0007422) | 2.57671685 |
| 154 | regulation of dopamine metabolic process (GO:0042053) | 2.57515336 |
| 155 | regulation of catecholamine metabolic process (GO:0042069) | 2.57515336 |
| 156 | neuronal ion channel clustering (GO:0045161) | 2.55840867 |
| 157 | negative regulation of JUN kinase activity (GO:0043508) | 2.52949571 |
| 158 | synaptic vesicle maturation (GO:0016188) | 2.52802926 |
| 159 | enteric nervous system development (GO:0048484) | 2.52220570 |
| 160 | positive regulation of glial cell differentiation (GO:0045687) | 2.52080385 |
| 161 | neural nucleus development (GO:0048857) | 2.48022693 |
| 162 | glial cell development (GO:0021782) | 2.47272212 |
| 163 | negative regulation of macroautophagy (GO:0016242) | 2.46983450 |
| 164 | neuron recognition (GO:0008038) | 2.45604790 |
| 165 | organ growth (GO:0035265) | 2.44631651 |
| 166 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.44217200 |
| 167 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.43400390 |
| 168 | cerebellar granule cell differentiation (GO:0021707) | 2.43086891 |
| 169 | cellular response to epinephrine stimulus (GO:0071872) | 2.41865928 |
| 170 | negative regulation of axon extension (GO:0030517) | 2.41666888 |
| 171 | heme transport (GO:0015886) | 2.41312456 |
| 172 | Golgi to endosome transport (GO:0006895) | 2.40960149 |
| 173 | response to lead ion (GO:0010288) | 2.39852511 |
| 174 | positive regulation of gliogenesis (GO:0014015) | 2.39018011 |
| 175 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.38594776 |
| 176 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.36927652 |
| 177 | dendritic spine morphogenesis (GO:0060997) | 2.36721803 |
| 178 | cellular response to catecholamine stimulus (GO:0071870) | 2.36316166 |
| 179 | axon ensheathment in central nervous system (GO:0032291) | 11.6316898 |
| 180 | central nervous system myelination (GO:0022010) | 11.6316898 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.23964498 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.17396489 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.17008709 |
| 4 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.64015965 |
| 5 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.57623565 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.52662205 |
| 7 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.49449674 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.31866285 |
| 9 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.19942356 |
| 10 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.13807353 |
| 11 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.13219956 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.12763961 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.12763961 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.08843531 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.08135537 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.05459193 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.03717198 |
| 18 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.02915243 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.00784083 |
| 20 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.00285156 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.98852338 |
| 22 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.98430131 |
| 23 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.96381456 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.93484097 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.91770852 |
| 26 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.91531082 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.90343550 |
| 28 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.89006844 |
| 29 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.84219130 |
| 30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.84201719 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.84117677 |
| 32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.83710267 |
| 33 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.82576896 |
| 34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.72798875 |
| 35 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.72301539 |
| 36 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.69717849 |
| 37 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.65255458 |
| 38 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.65097631 |
| 39 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.62414679 |
| 40 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.62308489 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.61753647 |
| 42 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.60994020 |
| 43 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.59312194 |
| 44 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.55241846 |
| 45 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.55001915 |
| 46 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.52481737 |
| 47 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.52266361 |
| 48 | VDR_22108803_ChIP-Seq_LS180_Human | 1.48748897 |
| 49 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.44365573 |
| 50 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.43182934 |
| 51 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.42901133 |
| 52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.42072771 |
| 53 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.40955932 |
| 54 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.39784829 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.39725705 |
| 56 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.39605949 |
| 57 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.38166049 |
| 58 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.36125546 |
| 59 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.34955086 |
| 60 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.34846458 |
| 61 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.34767052 |
| 62 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.33969795 |
| 63 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33082441 |
| 64 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.32732103 |
| 65 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.30827340 |
| 66 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.29984529 |
| 67 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.28930690 |
| 68 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.28445518 |
| 69 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.27879261 |
| 70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.26620785 |
| 71 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24104491 |
| 72 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.23937643 |
| 73 | P300_19829295_ChIP-Seq_ESCs_Human | 1.23576350 |
| 74 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.23476922 |
| 75 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.22492972 |
| 76 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.22492972 |
| 77 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.21880350 |
| 78 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20548421 |
| 79 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19555753 |
| 80 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.19086081 |
| 81 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.18741168 |
| 82 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.17470342 |
| 83 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17315790 |
| 84 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.16656706 |
| 85 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.16311752 |
| 86 | STAT3_23295773_ChIP-Seq_U87_Human | 1.12465394 |
| 87 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.09865545 |
| 88 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09538395 |
| 89 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.08508993 |
| 90 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.08402644 |
| 91 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.08210027 |
| 92 | FUS_26573619_Chip-Seq_HEK293_Human | 1.07033363 |
| 93 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06079988 |
| 94 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.04435455 |
| 95 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.03611694 |
| 96 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03080892 |
| 97 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.02434210 |
| 98 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01925309 |
| 99 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.01728241 |
| 100 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01040988 |
| 101 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.00957997 |
| 102 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.00728275 |
| 103 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.00530328 |
| 104 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.00530328 |
| 105 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.00262046 |
| 106 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.00034647 |
| 107 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99523026 |
| 108 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99340402 |
| 109 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.98294596 |
| 110 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.97920971 |
| 111 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.97286231 |
| 112 | TCF4_23295773_ChIP-Seq_U87_Human | 0.97211329 |
| 113 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96750890 |
| 114 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.96408548 |
| 115 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.96360919 |
| 116 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.96360919 |
| 117 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.95801036 |
| 118 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95109156 |
| 119 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.94514173 |
| 120 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.94432561 |
| 121 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.94284837 |
| 122 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.94142962 |
| 123 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93647145 |
| 124 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.93406465 |
| 125 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93231666 |
| 126 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.93006341 |
| 127 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.92776389 |
| 128 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.91739653 |
| 129 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.91706534 |
| 130 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.91643282 |
| 131 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.91418025 |
| 132 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.90933597 |
| 133 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.90469011 |
| 134 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90291597 |
| 135 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.90261147 |
| 136 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88892965 |
| 137 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.88774945 |
| 138 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.88691360 |
| 139 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.88275098 |
| 140 | AR_19668381_ChIP-Seq_PC3_Human | 0.87748206 |
| 141 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.87649306 |
| 142 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.86852701 |
| 143 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.86758408 |
| 144 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.86151475 |
| 145 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85993456 |
| 146 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.85964863 |
| 147 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.85179290 |
| 148 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.85137895 |
| 149 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.84109645 |
| 150 | MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.82290184 |
| 151 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.81907824 |
| 152 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.81857529 |
| 153 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.79341083 |
| 154 | * P68_20966046_ChIP-Seq_HELA_Human | 0.78812856 |
| 155 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.78559089 |
| 156 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.77680322 |
| 157 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.77420739 |
| 158 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.77125700 |
| 159 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.76432710 |
| 160 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.76222799 |
| 161 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.76041502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 5.20561239 |
| 2 | MP0003880_abnormal_central_pattern | 4.14919815 |
| 3 | MP0003950_abnormal_plasma_membrane | 3.39748130 |
| 4 | MP0004270_analgesia | 3.25006663 |
| 5 | MP0003690_abnormal_glial_cell | 3.06494773 |
| 6 | MP0003329_amyloid_beta_deposits | 2.93306254 |
| 7 | MP0001529_abnormal_vocalization | 2.85797950 |
| 8 | MP0002272_abnormal_nervous_system | 2.73013599 |
| 9 | MP0004859_abnormal_synaptic_plasticity | 2.70970836 |
| 10 | MP0001486_abnormal_startle_reflex | 2.59617842 |
| 11 | MP0004885_abnormal_endolymph | 2.54753833 |
| 12 | MP0005171_absent_coat_pigmentation | 2.50214192 |
| 13 | MP0001905_abnormal_dopamine_level | 2.49910322 |
| 14 | MP0004742_abnormal_vestibular_system | 2.49254562 |
| 15 | MP0002064_seizures | 2.47995164 |
| 16 | MP0004142_abnormal_muscle_tone | 2.27844590 |
| 17 | MP0003634_abnormal_glial_cell | 2.25732066 |
| 18 | MP0003635_abnormal_synaptic_transmissio | 2.17224342 |
| 19 | MP0005423_abnormal_somatic_nervous | 2.15296233 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 2.09160886 |
| 21 | MP0009745_abnormal_behavioral_response | 2.07167058 |
| 22 | MP0003879_abnormal_hair_cell | 2.04880024 |
| 23 | MP0003136_yellow_coat_color | 2.04531470 |
| 24 | MP0000778_abnormal_nervous_system | 2.03614757 |
| 25 | MP0001485_abnormal_pinna_reflex | 2.03465539 |
| 26 | MP0000751_myopathy | 1.96746950 |
| 27 | MP0009046_muscle_twitch | 1.93379169 |
| 28 | MP0005409_darkened_coat_color | 1.87160837 |
| 29 | MP0005410_abnormal_fertilization | 1.83476965 |
| 30 | MP0002734_abnormal_mechanical_nocicepti | 1.83256661 |
| 31 | MP0004043_abnormal_pH_regulation | 1.80494987 |
| 32 | MP0002229_neurodegeneration | 1.78884897 |
| 33 | MP0003632_abnormal_nervous_system | 1.76880019 |
| 34 | MP0002063_abnormal_learning/memory/cond | 1.68806088 |
| 35 | MP0002572_abnormal_emotion/affect_behav | 1.65967611 |
| 36 | MP0003631_nervous_system_phenotype | 1.62954990 |
| 37 | MP0003633_abnormal_nervous_system | 1.57672333 |
| 38 | MP0001984_abnormal_olfaction | 1.56347652 |
| 39 | MP0008569_lethality_at_weaning | 1.54103849 |
| 40 | MP0000604_amyloidosis | 1.52594826 |
| 41 | MP0001440_abnormal_grooming_behavior | 1.51726145 |
| 42 | MP0010678_abnormal_skin_adnexa | 1.49574787 |
| 43 | MP0004215_abnormal_myocardial_fiber | 1.48720044 |
| 44 | MP0001970_abnormal_pain_threshold | 1.46682816 |
| 45 | MP0003123_paternal_imprinting | 1.46124152 |
| 46 | MP0000955_abnormal_spinal_cord | 1.44795965 |
| 47 | MP0002822_catalepsy | 1.43635369 |
| 48 | MP0004134_abnormal_chest_morphology | 1.39542381 |
| 49 | MP0008260_abnormal_autophagy | 1.39497835 |
| 50 | MP0002882_abnormal_neuron_morphology | 1.38010238 |
| 51 | MP0005551_abnormal_eye_electrophysiolog | 1.37788245 |
| 52 | MP0000462_abnormal_digestive_system | 1.36360092 |
| 53 | MP0002067_abnormal_sensory_capabilities | 1.33736846 |
| 54 | MP0002066_abnormal_motor_capabilities/c | 1.32631822 |
| 55 | MP0004381_abnormal_hair_follicle | 1.28543268 |
| 56 | MP0003806_abnormal_nucleotide_metabolis | 1.28066117 |
| 57 | MP0001968_abnormal_touch/_nociception | 1.27345863 |
| 58 | MP0004510_myositis | 1.26862490 |
| 59 | MP0004924_abnormal_behavior | 1.24414405 |
| 60 | MP0005386_behavior/neurological_phenoty | 1.24414405 |
| 61 | MP0000383_abnormal_hair_follicle | 1.24410831 |
| 62 | MP0002733_abnormal_thermal_nociception | 1.18225223 |
| 63 | MP0000747_muscle_weakness | 1.18126721 |
| 64 | MP0005623_abnormal_meninges_morphology | 1.18011733 |
| 65 | MP0005451_abnormal_body_composition | 1.15994039 |
| 66 | MP0001963_abnormal_hearing_physiology | 1.15688459 |
| 67 | MP0003787_abnormal_imprinting | 1.13344030 |
| 68 | MP0008874_decreased_physiological_sensi | 1.12153976 |
| 69 | MP0003195_calcinosis | 1.11538085 |
| 70 | MP0002752_abnormal_somatic_nervous | 1.06789391 |
| 71 | MP0002736_abnormal_nociception_after | 1.06452204 |
| 72 | MP0005167_abnormal_blood-brain_barrier | 1.05637701 |
| 73 | MP0005058_abnormal_lysosome_morphology | 1.00816010 |
| 74 | MP0004145_abnormal_muscle_electrophysio | 0.99663280 |
| 75 | MP0001177_atelectasis | 0.99162807 |
| 76 | MP0001299_abnormal_eye_distance/ | 0.98283918 |
| 77 | MP0001501_abnormal_sleep_pattern | 0.95720701 |
| 78 | MP0001346_abnormal_lacrimal_gland | 0.95529129 |
| 79 | MP0005165_increased_susceptibility_to | 0.91361155 |
| 80 | MP0002735_abnormal_chemical_nociception | 0.91322546 |
| 81 | MP0000566_synostosis | 0.91239732 |
| 82 | MP0000647_abnormal_sebaceous_gland | 0.90061741 |
| 83 | MP0005330_cardiomyopathy | 0.88597770 |
| 84 | MP0002837_dystrophic_cardiac_calcinosis | 0.87528781 |
| 85 | MP0004087_abnormal_muscle_fiber | 0.87150097 |
| 86 | MP0004130_abnormal_muscle_cell | 0.87145843 |
| 87 | MP0002972_abnormal_cardiac_muscle | 0.87056021 |
| 88 | MP0005195_abnormal_posterior_eye | 0.87054535 |
| 89 | MP0002152_abnormal_brain_morphology | 0.84702056 |
| 90 | MP0005620_abnormal_muscle_contractility | 0.84586673 |
| 91 | MP0004084_abnormal_cardiac_muscle | 0.84255723 |
| 92 | MP0002184_abnormal_innervation | 0.83438493 |
| 93 | MP0002295_abnormal_pulmonary_circulatio | 0.81400336 |
| 94 | MP0002557_abnormal_social/conspecific_i | 0.81065469 |
| 95 | MP0001502_abnormal_circadian_rhythm | 0.78823248 |
| 96 | MP0005166_decreased_susceptibility_to | 0.77541622 |
| 97 | MP0005535_abnormal_body_temperature | 0.77163510 |
| 98 | MP0004147_increased_porphyrin_level | 0.77149797 |
| 99 | MP0001851_eye_inflammation | 0.76559206 |
| 100 | MP0000762_abnormal_tongue_morphology | 0.76463103 |
| 101 | MP0004484_altered_response_of | 0.75371557 |
| 102 | MP0000579_abnormal_nail_morphology | 0.74681747 |
| 103 | MP0003938_abnormal_ear_development | 0.74078535 |
| 104 | MP0004036_abnormal_muscle_relaxation | 0.73440300 |
| 105 | MP0004811_abnormal_neuron_physiology | 0.72686719 |
| 106 | MP0002269_muscular_atrophy | 0.72013403 |
| 107 | MP0004085_abnormal_heartbeat | 0.71025396 |
| 108 | MP0005253_abnormal_eye_physiology | 0.70759782 |
| 109 | MP0003656_abnormal_erythrocyte_physiolo | 0.69975468 |
| 110 | MP0000003_abnormal_adipose_tissue | 0.69619790 |
| 111 | MP0000749_muscle_degeneration | 0.68820058 |
| 112 | MP0002090_abnormal_vision | 0.68558892 |
| 113 | MP0009840_abnormal_foam_cell | 0.68360493 |
| 114 | MP0001661_extended_life_span | 0.68245137 |
| 115 | MP0000026_abnormal_inner_ear | 0.68077630 |
| 116 | MP0003137_abnormal_impulse_conducting | 0.66758382 |
| 117 | MP0005646_abnormal_pituitary_gland | 0.66303106 |
| 118 | MP0003075_altered_response_to | 0.65549708 |
| 119 | MP0005645_abnormal_hypothalamus_physiol | 0.64892900 |
| 120 | MP0000759_abnormal_skeletal_muscle | 0.64785170 |
| 121 | MP0005670_abnormal_white_adipose | 0.63931420 |
| 122 | MP0006276_abnormal_autonomic_nervous | 0.62429121 |
| 123 | MP0006072_abnormal_retinal_apoptosis | 0.61946646 |
| 124 | MP0005388_respiratory_system_phenotype | 0.58775270 |
| 125 | MP0002133_abnormal_respiratory_system | 0.58775270 |
| 126 | MP0002332_abnormal_exercise_endurance | 0.57937687 |
| 127 | MP0003191_abnormal_cellular_cholesterol | 0.57105869 |
| 128 | MP0002106_abnormal_muscle_physiology | 0.56777532 |
| 129 | MP0006036_abnormal_mitochondrial_physio | 0.55223569 |
| 130 | MP0002069_abnormal_eating/drinking_beha | 0.54526173 |
| 131 | MP0002638_abnormal_pupillary_reflex | 0.52120758 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 6.41653050 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.38423677 |
| 3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.38423677 |
| 4 | Abnormality of the corticospinal tract (HP:0002492) | 4.82429771 |
| 5 | Cerebral inclusion bodies (HP:0100314) | 4.71047207 |
| 6 | Peripheral hypomyelination (HP:0007182) | 4.49948545 |
| 7 | Parakeratosis (HP:0001036) | 4.28639279 |
| 8 | Sensory axonal neuropathy (HP:0003390) | 4.09970000 |
| 9 | Cerebral hypomyelination (HP:0006808) | 4.07578436 |
| 10 | Supranuclear gaze palsy (HP:0000605) | 4.07129330 |
| 11 | Onion bulb formation (HP:0003383) | 4.02186720 |
| 12 | Diplopia (HP:0000651) | 4.00206986 |
| 13 | Abnormality of binocular vision (HP:0011514) | 4.00206986 |
| 14 | Bundle branch block (HP:0011710) | 3.86911370 |
| 15 | Atonic seizures (HP:0010819) | 3.84442498 |
| 16 | Febrile seizures (HP:0002373) | 3.81175145 |
| 17 | Termporal pattern (HP:0011008) | 3.63459757 |
| 18 | Insidious onset (HP:0003587) | 3.63459757 |
| 19 | Myokymia (HP:0002411) | 3.59674959 |
| 20 | Spastic gait (HP:0002064) | 3.53784744 |
| 21 | Abnormal auditory evoked potentials (HP:0006958) | 3.51484260 |
| 22 | Dysmetria (HP:0001310) | 3.39101025 |
| 23 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.38949040 |
| 24 | Intention tremor (HP:0002080) | 3.31239584 |
| 25 | Ankle clonus (HP:0011448) | 3.24993529 |
| 26 | Scanning speech (HP:0002168) | 3.13627061 |
| 27 | Increased serum pyruvate (HP:0003542) | 3.12114126 |
| 28 | Abnormality of glycolysis (HP:0004366) | 3.12114126 |
| 29 | Leukodystrophy (HP:0002415) | 3.08676100 |
| 30 | Generalized tonic-clonic seizures (HP:0002069) | 3.07644054 |
| 31 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.04764009 |
| 32 | Sudden death (HP:0001699) | 3.02600541 |
| 33 | Retinal dysplasia (HP:0007973) | 3.02547245 |
| 34 | Alacrima (HP:0000522) | 2.97616450 |
| 35 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.94817647 |
| 36 | Visual hallucinations (HP:0002367) | 2.83986602 |
| 37 | Abnormal eating behavior (HP:0100738) | 2.81536124 |
| 38 | Slow saccadic eye movements (HP:0000514) | 2.80570335 |
| 39 | Absence seizures (HP:0002121) | 2.77781811 |
| 40 | Focal motor seizures (HP:0011153) | 2.75817000 |
| 41 | EMG: myopathic abnormalities (HP:0003458) | 2.70170037 |
| 42 | Mutism (HP:0002300) | 2.69150293 |
| 43 | Pheochromocytoma (HP:0002666) | 2.67942740 |
| 44 | Postural instability (HP:0002172) | 2.67717795 |
| 45 | Tetraplegia (HP:0002445) | 2.67043540 |
| 46 | CNS hypomyelination (HP:0003429) | 2.66562104 |
| 47 | Heart block (HP:0012722) | 2.65064080 |
| 48 | Truncal ataxia (HP:0002078) | 2.60802039 |
| 49 | Abnormal atrioventricular conduction (HP:0005150) | 2.59042901 |
| 50 | Delusions (HP:0000746) | 2.59025208 |
| 51 | Rigidity (HP:0002063) | 2.58605117 |
| 52 | Hypoplastic pelvis (HP:0008839) | 2.55068153 |
| 53 | Cerebral hemorrhage (HP:0001342) | 2.54439104 |
| 54 | Ventricular fibrillation (HP:0001663) | 2.52490279 |
| 55 | Axonal loss (HP:0003447) | 2.49508355 |
| 56 | Clumsiness (HP:0002312) | 2.49474821 |
| 57 | Torticollis (HP:0000473) | 2.49137911 |
| 58 | Dialeptic seizures (HP:0011146) | 2.47905085 |
| 59 | Anteriorly placed anus (HP:0001545) | 2.47356917 |
| 60 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.46614341 |
| 61 | Obstructive sleep apnea (HP:0002870) | 2.46381267 |
| 62 | Depression (HP:0000716) | 2.46358034 |
| 63 | Rapidly progressive (HP:0003678) | 2.43839264 |
| 64 | Thickened helices (HP:0000391) | 2.42415797 |
| 65 | Lower limb amyotrophy (HP:0007210) | 2.42368299 |
| 66 | Syncope (HP:0001279) | 2.41939406 |
| 67 | Exercise-induced muscle cramps (HP:0003710) | 2.41250603 |
| 68 | Increased circulating renin level (HP:0000848) | 2.40275587 |
| 69 | Action tremor (HP:0002345) | 2.38426603 |
| 70 | Morphological abnormality of the inner ear (HP:0011390) | 2.38230450 |
| 71 | Absent septum pellucidum (HP:0001331) | 2.37934204 |
| 72 | Stridor (HP:0010307) | 2.36769163 |
| 73 | Spastic paraparesis (HP:0002313) | 2.35460402 |
| 74 | Insomnia (HP:0100785) | 2.35245783 |
| 75 | Neuroendocrine neoplasm (HP:0100634) | 2.34387785 |
| 76 | Decreased lacrimation (HP:0000633) | 2.33204914 |
| 77 | Progressive cerebellar ataxia (HP:0002073) | 2.32128507 |
| 78 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.31570397 |
| 79 | Aplasia of the phalanges of the hand (HP:0009802) | 2.31570397 |
| 80 | Aplasia involving bones of the extremities (HP:0009825) | 2.31570397 |
| 81 | Megalencephaly (HP:0001355) | 2.30989842 |
| 82 | Split foot (HP:0001839) | 2.30802289 |
| 83 | Lower limb muscle weakness (HP:0007340) | 2.30585274 |
| 84 | Foot dorsiflexor weakness (HP:0009027) | 2.30078122 |
| 85 | Spastic tetraparesis (HP:0001285) | 2.29337752 |
| 86 | Anxiety (HP:0000739) | 2.28680069 |
| 87 | Metabolic alkalosis (HP:0200114) | 2.28366861 |
| 88 | Autoamputation (HP:0001218) | 2.26544072 |
| 89 | Focal dystonia (HP:0004373) | 2.25473983 |
| 90 | Abnormality of the periventricular white matter (HP:0002518) | 2.22830843 |
| 91 | Apathy (HP:0000741) | 2.22687693 |
| 92 | Muscle fiber inclusion bodies (HP:0100299) | 2.20358410 |
| 93 | Premature skin wrinkling (HP:0100678) | 2.19470659 |
| 94 | Nemaline bodies (HP:0003798) | 2.18322587 |
| 95 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.15781696 |
| 96 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.15726898 |
| 97 | Ventricular arrhythmia (HP:0004308) | 2.14421230 |
| 98 | Poor speech (HP:0002465) | 2.13508029 |
| 99 | Bradykinesia (HP:0002067) | 2.12701833 |
| 100 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.10717307 |
| 101 | Exercise-induced myalgia (HP:0003738) | 2.09561287 |
| 102 | Slow progression (HP:0003677) | 2.09308695 |
| 103 | Urinary urgency (HP:0000012) | 2.08077760 |
| 104 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.07845196 |
| 105 | Abnormality of the foot musculature (HP:0001436) | 2.07778139 |
| 106 | Distal lower limb muscle weakness (HP:0009053) | 2.07047523 |
| 107 | Atrial fibrillation (HP:0005110) | 2.06385490 |
| 108 | Hypoplasia of the iris (HP:0007676) | 2.05744280 |
| 109 | Craniofacial dystonia (HP:0012179) | 2.05575532 |
| 110 | Clonus (HP:0002169) | 2.04873101 |
| 111 | Papilledema (HP:0001085) | 2.04239458 |
| 112 | Hemiparesis (HP:0001269) | 2.03586599 |
| 113 | Hemiplegia (HP:0002301) | 2.03042965 |
| 114 | Muscle fiber splitting (HP:0003555) | 2.02601103 |
| 115 | Akinesia (HP:0002304) | 2.01904952 |
| 116 | Diminished motivation (HP:0000745) | 2.01225828 |
| 117 | White forelock (HP:0002211) | 2.01073741 |
| 118 | Poor eye contact (HP:0000817) | 2.00802634 |
| 119 | Decreased motor nerve conduction velocity (HP:0003431) | 2.00506170 |
| 120 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.00409833 |
| 121 | Primary atrial arrhythmia (HP:0001692) | 2.00182141 |
| 122 | Sleep apnea (HP:0010535) | 1.99900738 |
| 123 | Annular pancreas (HP:0001734) | 1.99755824 |
| 124 | Supraventricular tachycardia (HP:0004755) | 1.99262687 |
| 125 | Hypokalemic alkalosis (HP:0001949) | 1.98841724 |
| 126 | Abnormality of the septum pellucidum (HP:0007375) | 1.98314666 |
| 127 | Patchy hypopigmentation of hair (HP:0011365) | 1.97503072 |
| 128 | Hepatosplenomegaly (HP:0001433) | 1.97360314 |
| 129 | Atrioventricular block (HP:0001678) | 1.96678844 |
| 130 | Status epilepticus (HP:0002133) | 1.96627355 |
| 131 | Choreoathetosis (HP:0001266) | 1.96220155 |
| 132 | Coronal craniosynostosis (HP:0004440) | 1.95616404 |
| 133 | Hypomagnesemia (HP:0002917) | 1.94485979 |
| 134 | Methylmalonic acidemia (HP:0002912) | 1.93626088 |
| 135 | Hammertoe (HP:0001765) | 1.92253264 |
| 136 | Limb dystonia (HP:0002451) | 1.89637866 |
| 137 | Paraparesis (HP:0002385) | 1.88994867 |
| 138 | Focal seizures (HP:0007359) | 1.88326346 |
| 139 | Bowel incontinence (HP:0002607) | 1.87059452 |
| 140 | Dysdiadochokinesis (HP:0002075) | 1.84347074 |
| 141 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.82848391 |
| 142 | Epileptic encephalopathy (HP:0200134) | 1.82699506 |
| 143 | Neuronal loss in central nervous system (HP:0002529) | 1.82684068 |
| 144 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.82660747 |
| 145 | Gowers sign (HP:0003391) | 1.82519343 |
| 146 | Distal sensory impairment (HP:0002936) | 1.82368164 |
| 147 | Infantile muscular hypotonia (HP:0008947) | 1.82190327 |
| 148 | Urinary incontinence (HP:0000020) | 1.81936429 |
| 149 | Humeroradial synostosis (HP:0003041) | 1.79575899 |
| 150 | Synostosis involving the elbow (HP:0003938) | 1.79575899 |
| 151 | Esophageal atresia (HP:0002032) | 1.77740446 |
| 152 | Hypophosphatemic rickets (HP:0004912) | 1.77373067 |
| 153 | Hyporeflexia of lower limbs (HP:0002600) | 1.75314533 |
| 154 | Acute necrotizing encephalopathy (HP:0006965) | 1.75266556 |
| 155 | Vaginal atresia (HP:0000148) | 1.74997545 |
| 156 | Abnormal large intestine physiology (HP:0012700) | 1.74584199 |
| 157 | Broad-based gait (HP:0002136) | 1.72063486 |
| 158 | Peripheral demyelination (HP:0011096) | 1.71208694 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.95720105 |
| 2 | OXSR1 | 4.15098658 |
| 3 | EPHB1 | 3.43737940 |
| 4 | MAPKAPK5 | 3.29709427 |
| 5 | PKN1 | 2.73956314 |
| 6 | BCR | 2.53371051 |
| 7 | PBK | 2.49925417 |
| 8 | WNK4 | 2.42764212 |
| 9 | FGFR2 | 2.15249016 |
| 10 | UHMK1 | 2.10690304 |
| 11 | CDK19 | 2.09030867 |
| 12 | WNK1 | 1.98496204 |
| 13 | RIPK1 | 1.92391511 |
| 14 | LIMK1 | 1.89593374 |
| 15 | MET | 1.86958720 |
| 16 | PNCK | 1.82799605 |
| 17 | CAMK2B | 1.73673642 |
| 18 | CAMKK1 | 1.68970431 |
| 19 | TNIK | 1.68563777 |
| 20 | EPHA4 | 1.66754961 |
| 21 | NTRK1 | 1.65481774 |
| 22 | CSNK1G3 | 1.64858570 |
| 23 | CSNK1A1L | 1.57850991 |
| 24 | SGK494 | 1.57732137 |
| 25 | SGK223 | 1.57732137 |
| 26 | TESK1 | 1.57245825 |
| 27 | LATS2 | 1.50793486 |
| 28 | ROCK2 | 1.49445097 |
| 29 | NEK6 | 1.41053967 |
| 30 | CAMK2D | 1.38993783 |
| 31 | CASK | 1.37941845 |
| 32 | TESK2 | 1.37377387 |
| 33 | PAK6 | 1.32816697 |
| 34 | CSNK1G2 | 1.31348580 |
| 35 | MST4 | 1.30642102 |
| 36 | OBSCN | 1.29947343 |
| 37 | DAPK1 | 1.29113975 |
| 38 | MAP3K12 | 1.27512115 |
| 39 | PRPF4B | 1.26943853 |
| 40 | CLK1 | 1.26187248 |
| 41 | CSNK1G1 | 1.23957143 |
| 42 | MARK1 | 1.23016715 |
| 43 | FGR | 1.22382635 |
| 44 | CAMK1 | 1.18017541 |
| 45 | CAMK2G | 1.13638220 |
| 46 | MAPK12 | 1.12897091 |
| 47 | LMTK2 | 1.09445310 |
| 48 | TYRO3 | 1.05782659 |
| 49 | ILK | 1.00338315 |
| 50 | CAMK2A | 0.99518528 |
| 51 | DYRK2 | 0.97002402 |
| 52 | CDK5 | 0.93938947 |
| 53 | MAP3K11 | 0.92080817 |
| 54 | ALK | 0.91721260 |
| 55 | TTN | 0.91318032 |
| 56 | CDK14 | 0.91070754 |
| 57 | MARK2 | 0.90414032 |
| 58 | MYLK | 0.90159587 |
| 59 | PRKD1 | 0.88417386 |
| 60 | PRKCG | 0.88279637 |
| 61 | PHKG2 | 0.87309494 |
| 62 | PHKG1 | 0.87309494 |
| 63 | MUSK | 0.84857629 |
| 64 | PDK2 | 0.84050669 |
| 65 | KSR2 | 0.83678181 |
| 66 | CDK15 | 0.82669784 |
| 67 | PAK3 | 0.81356769 |
| 68 | ARAF | 0.80234667 |
| 69 | MAPK10 | 0.79471384 |
| 70 | PRKCQ | 0.78585001 |
| 71 | ICK | 0.78535008 |
| 72 | CDK18 | 0.78265399 |
| 73 | PRKCE | 0.75095366 |
| 74 | PINK1 | 0.74563700 |
| 75 | RIPK4 | 0.73995459 |
| 76 | PRKD3 | 0.73714234 |
| 77 | BRSK1 | 0.73615664 |
| 78 | CDK11A | 0.73368629 |
| 79 | MAPK15 | 0.71425209 |
| 80 | STK38 | 0.70332737 |
| 81 | NTRK2 | 0.69893569 |
| 82 | BRAF | 0.69540483 |
| 83 | PDPK1 | 0.67458049 |
| 84 | SGK3 | 0.65975612 |
| 85 | NTRK3 | 0.64061626 |
| 86 | PRKG2 | 0.62264810 |
| 87 | MAPK13 | 0.62131676 |
| 88 | ROCK1 | 0.61714135 |
| 89 | CAMKK2 | 0.61006883 |
| 90 | SGK1 | 0.60146427 |
| 91 | IRAK2 | 0.55006167 |
| 92 | RPS6KA3 | 0.54903969 |
| 93 | RPS6KA5 | 0.54810400 |
| 94 | BMPR1B | 0.54616345 |
| 95 | MAP3K9 | 0.54585366 |
| 96 | FYN | 0.53153262 |
| 97 | SGK2 | 0.52576963 |
| 98 | MAP3K13 | 0.52078635 |
| 99 | MAP3K1 | 0.50234313 |
| 100 | MAP3K2 | 0.49207204 |
| 101 | CAMK4 | 0.49079626 |
| 102 | ABL2 | 0.48667382 |
| 103 | PRKCH | 0.48332814 |
| 104 | PRKG1 | 0.47656290 |
| 105 | RAF1 | 0.46438266 |
| 106 | MINK1 | 0.46222305 |
| 107 | CSNK1A1 | 0.46050223 |
| 108 | MAP2K2 | 0.45423075 |
| 109 | FES | 0.45182037 |
| 110 | GRK7 | 0.44366372 |
| 111 | CSNK1D | 0.43757504 |
| 112 | DAPK3 | 0.43546915 |
| 113 | PRKACB | 0.43441256 |
| 114 | PTK2 | 0.43195109 |
| 115 | PLK2 | 0.42910476 |
| 116 | PRKCZ | 0.42492610 |
| 117 | SIK2 | 0.41838558 |
| 118 | CAMK1G | 0.41526655 |
| 119 | BMPR2 | 0.40924282 |
| 120 | GSK3A | 0.40576064 |
| 121 | GRK5 | 0.39423160 |
| 122 | MAP3K4 | 0.39206792 |
| 123 | CCNB1 | 0.38639911 |
| 124 | STK11 | 0.38518775 |
| 125 | KSR1 | 0.37403594 |
| 126 | PRKCA | 0.37168688 |
| 127 | DAPK2 | 0.35598237 |
| 128 | PTK2B | 0.35230247 |
| 129 | PDK1 | 0.35012072 |
| 130 | MAP2K7 | 0.34701880 |
| 131 | PRKACA | 0.33947740 |
| 132 | ADRBK2 | 0.33916485 |
| 133 | ERBB4 | 0.33764583 |
| 134 | DYRK1A | 0.32995787 |
| 135 | PAK1 | 0.32345335 |
| 136 | DMPK | 0.30387529 |
| 137 | MKNK1 | 0.29443165 |
| 138 | TRPM7 | 0.29361716 |
| 139 | PIK3CA | 0.28457970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.04413999 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.26490020 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.22210937 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.17276224 |
| 5 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.92291230 |
| 6 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.66240052 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.56565052 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.55901329 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.19464873 |
| 10 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.04994633 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.00252598 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.76357258 |
| 13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.71664222 |
| 14 | GABAergic synapse_Homo sapiens_hsa04727 | 1.66809350 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.61945750 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.61300043 |
| 17 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.60645020 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.57299911 |
| 19 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.54393483 |
| 20 | Parkinsons disease_Homo sapiens_hsa05012 | 1.52611598 |
| 21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.51773796 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49069118 |
| 23 | Axon guidance_Homo sapiens_hsa04360 | 1.48749518 |
| 24 | Alzheimers disease_Homo sapiens_hsa05010 | 1.43866815 |
| 25 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.39210410 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.39122323 |
| 27 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.38741193 |
| 28 | Protein export_Homo sapiens_hsa03060 | 1.38285712 |
| 29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.35495757 |
| 30 | Morphine addiction_Homo sapiens_hsa05032 | 1.32896540 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.31836367 |
| 32 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.29194498 |
| 33 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.29061557 |
| 34 | Long-term depression_Homo sapiens_hsa04730 | 1.26066103 |
| 35 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.21808862 |
| 36 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.18235753 |
| 37 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.17741417 |
| 38 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.16057081 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.14305942 |
| 40 | Circadian entrainment_Homo sapiens_hsa04713 | 1.10568418 |
| 41 | Nicotine addiction_Homo sapiens_hsa05033 | 1.09051647 |
| 42 | Cocaine addiction_Homo sapiens_hsa05030 | 1.08488840 |
| 43 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08376715 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.06274479 |
| 45 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.04891767 |
| 46 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.04303152 |
| 47 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01202443 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 1.01022276 |
| 49 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.98980642 |
| 50 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.98749043 |
| 51 | Salivary secretion_Homo sapiens_hsa04970 | 0.95913653 |
| 52 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.93794898 |
| 53 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.92063115 |
| 54 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.91907360 |
| 55 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.91565373 |
| 56 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.89983584 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.88998865 |
| 58 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.86362482 |
| 59 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.84467186 |
| 60 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.82894758 |
| 61 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.82049061 |
| 62 | Circadian rhythm_Homo sapiens_hsa04710 | 0.81044375 |
| 63 | Glioma_Homo sapiens_hsa05214 | 0.78352350 |
| 64 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77630661 |
| 65 | Tight junction_Homo sapiens_hsa04530 | 0.77622285 |
| 66 | Melanogenesis_Homo sapiens_hsa04916 | 0.75673787 |
| 67 | Phototransduction_Homo sapiens_hsa04744 | 0.74262838 |
| 68 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.73854211 |
| 69 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.73610590 |
| 70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73491467 |
| 71 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.72312694 |
| 72 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.70962801 |
| 73 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.70822878 |
| 74 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.70243658 |
| 75 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.69536670 |
| 76 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68911518 |
| 77 | Huntingtons disease_Homo sapiens_hsa05016 | 0.68818489 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67638100 |
| 79 | Renin secretion_Homo sapiens_hsa04924 | 0.67467116 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.66975840 |
| 81 | Olfactory transduction_Homo sapiens_hsa04740 | 0.66933745 |
| 82 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.66465006 |
| 83 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.66125821 |
| 84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65817662 |
| 85 | Mineral absorption_Homo sapiens_hsa04978 | 0.64538581 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.63213352 |
| 87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62757120 |
| 88 | Taste transduction_Homo sapiens_hsa04742 | 0.62116801 |
| 89 | Gap junction_Homo sapiens_hsa04540 | 0.61467118 |
| 90 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.60490235 |
| 91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.59851137 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59270560 |
| 93 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.58813872 |
| 94 | Long-term potentiation_Homo sapiens_hsa04720 | 0.58374347 |
| 95 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57594129 |
| 96 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.56183013 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55125604 |
| 98 | Lysosome_Homo sapiens_hsa04142 | 0.53462223 |
| 99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52627567 |
| 100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50705698 |
| 101 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.49833250 |
| 102 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49641314 |
| 103 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.49564820 |
| 104 | Carbon metabolism_Homo sapiens_hsa01200 | 0.48606488 |
| 105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48428692 |
| 106 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.47757175 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47623527 |
| 108 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46976020 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46155492 |
| 110 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45782873 |
| 111 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.45053958 |
| 112 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44762318 |
| 113 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44611034 |
| 114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.44282984 |
| 115 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.43555927 |
| 116 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43497001 |
| 117 | Insulin secretion_Homo sapiens_hsa04911 | 0.43342212 |
| 118 | Phagosome_Homo sapiens_hsa04145 | 0.43130968 |
| 119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41883604 |
| 120 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.41534677 |
| 121 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.39989562 |
| 122 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39694638 |
| 123 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37751060 |
| 124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37040488 |
| 125 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.36549412 |
| 126 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36078637 |
| 127 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35527335 |
| 128 | Peroxisome_Homo sapiens_hsa04146 | 0.35350838 |
| 129 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.34803585 |
| 130 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.33808300 |
| 131 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33571408 |
| 132 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.33403104 |
| 133 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.32642704 |
| 134 | Prion diseases_Homo sapiens_hsa05020 | 0.32049391 |
| 135 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.31835272 |
| 136 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28564355 |
| 137 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.26611083 |

